Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Nicholas A Tritos, D.Sc., M.D.

Co-Author

Back to Details
This page shows the publications co-authored by Nicholas Tritos and Anne Klibanski.
Nicholas Tritos
Connection Strength
6.120
Anne Klibanski
  1. Effects of Growth Hormone on Bone. Prog Mol Biol Transl Sci. 2016; 138:193-211.
    View in: PubMed
    Score: 0.646
  2. Hyperprolactinemia. JAMA. 2015 Oct 27; 314(16):1742-3.
    View in: PubMed
    Score: 0.638
  3. Pathologic and clinical features of pituitary adenomas showing TSH immunoreactivity. Pituitary. 2013 Sep; 16(3):287-93.
    View in: PubMed
    Score: 0.549
  4. Diabetes insipidus. J Clin Endocrinol Metab. 2013 Jul; 98(7):35A-36A.
    View in: PubMed
    Score: 0.543
  5. A patient with diabetes insipidus, anterior hypopituitarism and pituitary stalk thickening. Nat Rev Endocrinol. 2011 Jan; 7(1):54-9.
    View in: PubMed
    Score: 0.453
  6. MRI texture analysis in acromegaly and its role in predicting response to somatostatin receptor ligands. Pituitary. 2020 Jun; 23(3):212-222.
    View in: PubMed
    Score: 0.219
  7. Accuracy of Laboratory Tests for the Diagnosis of Cushing Syndrome. J Clin Endocrinol Metab. 2020 06 01; 105(6).
    View in: PubMed
    Score: 0.219
  8. All-cause mortality in patients with acromegaly treated with pegvisomant: an ACROSTUDY analysis. Eur J Endocrinol. 2020 Mar; 182(3):285-292.
    View in: PubMed
    Score: 0.215
  9. MANAGEMENT OF ENDOCRINE DISEASE: Impulse control disorders in patients with hyperpolactinemia treated with dopamine agonists: how much should we worry? Eur J Endocrinol. 2018 Dec 01; 179(6):R287-R296.
    View in: PubMed
    Score: 0.198
  10. MRI texture analysis as a predictor of tumor recurrence or progression in patients with clinically non-functioning pituitary adenomas. Eur J Endocrinol. 2018 Sep; 179(3):191-198.
    View in: PubMed
    Score: 0.192
  11. Characterization of cyclic Cushing's disease using late night salivary cortisol testing. Clin Endocrinol (Oxf). 2018 09; 89(3):336-345.
    View in: PubMed
    Score: 0.192
  12. Effects of growth hormone therapy on bone density and fracture risk in age-related osteoporosis in the absence of growth hormone deficiency: a systematic review and meta-analysis. Endocrine. 2018 01; 59(1):39-49.
    View in: PubMed
    Score: 0.183
  13. Bone microarchitecture and estimated bone strength in men with active acromegaly. Eur J Endocrinol. 2017 Nov; 177(5):409-420.
    View in: PubMed
    Score: 0.180
  14. Effectiveness of first-line pegvisomant monotherapy in acromegaly: an ACROSTUDY analysis. Eur J Endocrinol. 2017 Feb; 176(2):213-220.
    View in: PubMed
    Score: 0.171
  15. Neuroendocrine disorders: pituitary imaging. Handb Clin Neurol. 2016; 136:873-85.
    View in: PubMed
    Score: 0.161
  16. Predictors of Hypopituitarism in Patients with Traumatic Brain Injury. J Neurotrauma. 2015 Nov 15; 32(22):1789-95.
    View in: PubMed
    Score: 0.159
  17. Accuracy of Late-Night Salivary Cortisol in Evaluating Postoperative Remission and Recurrence in Cushing's Disease. J Clin Endocrinol Metab. 2015 Oct; 100(10):3770-7.
    View in: PubMed
    Score: 0.156
  18. Effects of long-term growth hormone replacement in adults with growth hormone deficiency following cure of acromegaly: a KIMS analysis. J Clin Endocrinol Metab. 2014 Jun; 99(6):2018-29.
    View in: PubMed
    Score: 0.143
  19. Investigation of impulsivity in patients on dopamine agonist therapy for hyperprolactinemia: a pilot study. Pituitary. 2014 Apr; 17(2):150-6.
    View in: PubMed
    Score: 0.143
  20. Effects of recombinant human growth hormone therapy on bone mineral density in adults with growth hormone deficiency: a meta-analysis. J Clin Endocrinol Metab. 2014 Mar; 99(3):852-60.
    View in: PubMed
    Score: 0.141
  21. Hypopituitarism. J Clin Endocrinol Metab. 2013 Nov; 98(11):43A-44A.
    View in: PubMed
    Score: 0.139
  22. Traumatic brain injury: effects on the endocrine system. J Clin Endocrinol Metab. 2013 Mar; 98(3):27A-8A.
    View in: PubMed
    Score: 0.133
  23. Effects of recombinant human growth hormone therapy in adults with Prader-Willi syndrome: a meta-analysis. Clin Endocrinol (Oxf). 2012 Jul; 77(1):86-93.
    View in: PubMed
    Score: 0.127
  24. CLINICAL OUTCOMES AND SELF-REPORTED SYMPTOMS IN PATIENTS WITH ACROMEGALY: AN 8-YEAR FOLLOW-UP OF A LANREOTIDE STUDY. Endocr Pract. 2017 Jan; 23(1):56-65.
    View in: PubMed
    Score: 0.042
  25. Monotherapy with lanreotide depot for acromegaly: long-term clinical experience in a pituitary center. Pituitary. 2016 Aug; 19(4):437-47.
    View in: PubMed
    Score: 0.042
  26. The effect of somatostatin analogs on vitamin D and calcium concentrations in patients with acromegaly. Pituitary. 2014 Aug; 17(4):366-73.
    View in: PubMed
    Score: 0.037
  27. Ipilimumab-induced hypophysitis: a detailed longitudinal analysis in a large cohort of patients with metastatic melanoma. J Clin Endocrinol Metab. 2014 Nov; 99(11):4078-85.
    View in: PubMed
    Score: 0.037
  28. Effects of growth hormone deficiency on body composition and biomarkers of cardiovascular risk after definitive therapy for acromegaly. Clin Endocrinol (Oxf). 2012 Sep; 77(3):430-8.
    View in: PubMed
    Score: 0.032
  29. Transsphenoidal surgery for cushing disease after nondiagnostic inferior petrosal sinus sampling. Neurosurgery. 2012 Jul; 71(1):14-22.
    View in: PubMed
    Score: 0.032
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.